Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
- PMID: 24053983
- PMCID: PMC4058297
- DOI: 10.1016/j.pediatrneurol.2013.08.002
Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
Abstract
Background: Tuberous sclerosis complex is a genetic disorder affecting every organ system, but disease manifestations vary significantly among affected individuals. The diverse and varied presentations and progression can be life-threatening with significant impact on cost and quality of life. Current surveillance and management practices are highly variable among region and country, reflective of the fact that last consensus recommendations occurred in 1998 and an updated, comprehensive standard is lacking that incorporates the latest scientific evidence and current best clinical practices.
Methods: The 2012 International Tuberous Sclerosis Complex Consensus Group, comprising 79 specialists from 14 countries, was organized into 12 separate subcommittees, each led by a clinician with advanced expertise in tuberous sclerosis complex and the relevant medical subspecialty. Each subcommittee focused on a specific disease area with important clinical management implications and was charged with formulating key clinical questions to address within its focus area, reviewing relevant literature, evaluating the strength of data, and providing a recommendation accordingly.
Results: The updated consensus recommendations for clinical surveillance and management in tuberous sclerosis complex are summarized here. The recommendations are relevant to the entire lifespan of the patient, from infancy to adulthood, including both individuals where the diagnosis is newly made as well as individuals where the diagnosis already is established.
Conclusions: The 2012 International Tuberous Sclerosis Complex Consensus Recommendations provide an evidence-based, standardized approach for optimal clinical care provided for individuals with tuberous sclerosis complex.
Keywords: guideline; management; surveillance; treatment; tuberous sclerosis.
Copyright © 2013 The Authors. Published by Elsevier Inc. All rights reserved.
Comment in
-
Are diagnostic criteria for tuberous sclerosis still relevant?Pediatr Neurol. 2013 Oct;49(4):223-4. doi: 10.1016/j.pediatrneurol.2013.08.003. Pediatr Neurol. 2013. PMID: 24053981 No abstract available.
Similar articles
-
Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference.Pediatr Neurol. 2013 Oct;49(4):243-54. doi: 10.1016/j.pediatrneurol.2013.08.001. Pediatr Neurol. 2013. PMID: 24053982 Free PMC article.
-
The UK guidelines for management and surveillance of Tuberous Sclerosis Complex.QJM. 2019 Mar 1;112(3):171-182. doi: 10.1093/qjmed/hcy215. QJM. 2019. PMID: 30247655
-
Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations.Pediatr Neurol. 2021 Oct;123:50-66. doi: 10.1016/j.pediatrneurol.2021.07.011. Epub 2021 Jul 24. Pediatr Neurol. 2021. PMID: 34399110
-
Dermatologic and dental aspects of the 2012 International Tuberous Sclerosis Complex Consensus Statements.JAMA Dermatol. 2014 Oct;150(10):1095-101. doi: 10.1001/jamadermatol.2014.938. JAMA Dermatol. 2014. PMID: 25029267 Free PMC article.
-
Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.Fertil Steril. 2018 Aug;110(3):364-379. doi: 10.1016/j.fertnstert.2018.05.004. Epub 2018 Jul 19. Fertil Steril. 2018. PMID: 30033227 Free PMC article. Review.
Cited by
-
Combined targeted treatment in early onset epilepsy associated with tuberous sclerosis.Epilepsy Behav Case Rep. 2016 Jan 13;5:13-6. doi: 10.1016/j.ebcr.2015.12.001. eCollection 2016. Epilepsy Behav Case Rep. 2016. PMID: 27330989 Free PMC article.
-
A single-center observational study on long-term neurodevelopmental outcomes in children with tuberous sclerosis complex.Orphanet J Rare Dis. 2023 Nov 9;18(1):349. doi: 10.1186/s13023-023-02959-0. Orphanet J Rare Dis. 2023. PMID: 37946245 Free PMC article.
-
Renal Manifestations of Tuberous Sclerosis Complex.J Kidney Cancer VHL. 2020 Aug 27;7(3):5-19. doi: 10.15586/jkcvhl.2020.131. eCollection 2020. J Kidney Cancer VHL. 2020. PMID: 32953421 Free PMC article. Review.
-
The Adult Phenotype of Tuberous Sclerosis Complex.Acta Derm Venereol. 2016 Feb;96(2):278-80. doi: 10.2340/00015555-2203. Acta Derm Venereol. 2016. PMID: 26258325 Free PMC article. No abstract available.
-
Neurocutaneous syndromes in art and antiquities.Am J Med Genet C Semin Med Genet. 2021 Jun;187(2):224-234. doi: 10.1002/ajmg.c.31917. Epub 2021 May 20. Am J Med Genet C Semin Med Genet. 2021. PMID: 34013593 Free PMC article. Review.
References
-
- Jozwiak S, Schwartz RA, Janniger CK, Bielicka-Cymerman J. Usefulness of diagnostic criteria of tuberous sclerosis complex in pediatric patients. J Child Neurol. 2000;15:652–659. - PubMed
-
- O’Callaghan F, Shiell A, Osborne J, Martyn C. Prevalence of tuberous sclerosis estimated by capture-recapture analysis. Lancet. 1998;352:318–319. - PubMed
-
- Roach E, DiMario F, Kandt R, Northrup H. Tuberous Sclerosis Consensus Conference: recommendations for diagnostic evaluation. National Tuberous Sclerosis Association. J Child Neurol. 1999;14:401–407. - PubMed
-
- Roach E, Gomez M, Northrup H. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol. 1998;13:624–628. - PubMed
-
- European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell. 1993;75:1305–1315. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical